Outsourcing

While we previously discussed how rare disease research has dramatically increased in both academic and industrial research, clinical trials of...

We previously discussed how there are software methods to screen for potential drug leads and researchers have been able to increase their drug...

Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery...

Traditional drug discovery is expensive, inefficient, and has huge barriers to entry. Big pharmaceutical companies continue to struggle to cope...

This is Part 3 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 2). Big Data — the vast amount...

The need for CNS therapeutics is on the rise. Neurological diseases are expected to increase steadily in the coming years. Previously, we addressed...

This is Part 3 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 2). Use of CROs in research and drug development...

This is Part 2 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 3). Contract research organizations (CROs) often...

Kevin Lustig was invited by The Empowered Patient Radio Show after they heard Kevin at the Tech Coast Angels quick pitch competition. Kevin...

This is Part 1 in a three-part series on key factors in CRO selection. (Check out Part 2 and Part 3). Alternative strategies for approaching drug...